Category Archives: Drug Side Effects

11-07-2012 12:02 To read the entire article, click here: To find out more about medical conditions, unsafe products and drugs, click here: Originally posted here: Permax Drug Side Effects - Video … Continue reading →

Kevin Malley was almost 30, and he was starting to lose his hair. He went to his doctor to see if there was a way to keep from going bald, and his doctor prescribed Propecia. "I looked young for my age, so I wanted to hold off my hair loss for a little bit," Malley said. "I didn't plan on taking Propecia for more than a year." Malley started taking the drug in May 2011, and by October he was completely impotent and had no sex drive whatsoever. His body changed, even his genitals shrank, and he slipped into a mental fog that he just couldn't clear. His doctor told him the side effects would go away if he stopped taking the drug, so he did. But nothing changed. "I kept expecting the side effects to go away, but they did not, they only got worse," he said. Malley is not alone: A new study published today in the Journal of Sexual Medicine suggests that for some men, the sexual side effects of Propecia may last for months to years, even after they stop taking the drug. Researchers from George Washington University interviewed 54 men under age 40 who reported … Continue reading →

Kevin Malley was almost 30, and he was starting to lose his hair. He went to his doctor to see if there was a way to keep from going bald, and his doctor prescribed Propecia. "I looked young for my age, so I wanted to hold off my hair loss for a little bit," Malley said. "I didn't plan on taking Propecia for more than a year." Malley started taking the drug in May 2011, and by October he was completely impotent and had no sex drive whatsoever. His body changed, even his genitals shrank, and he slipped into a mental fog that he just couldn't clear. His doctor told him the side effects would go away if he stopped taking the drug, so he did. But nothing changed. "I kept expecting the side effects to go away, but they did not, they only got worse," he said. Malley is not alone: A new study published today in the Journal of Sexual Medicine suggests that for some men, the sexual side effects of Propecia may last for months to years, even after they stop taking the drug. Researchers from George Washington University interviewed 54 men under age 40 who reported … Continue reading →

09-07-2012 23:29 Many people ignore prescription drug warning labels according to a study published in the June 2012 issue of the Public Library of Science online journal. There are 15 million drug errors annually in the US, 2 million hospitalizations, and 400000 deaths. In a study measuring eye gaze when reading a prescription drug label in people over 50 years of age, 50% failed to notice a warning label and for 22% they did not even gaze at the area! In people between 20 and 29, 90% fixated on the warning label. Even MDs don't pay as much attention to side effects as they do to the intended effects. This is not surprising since the goal of medical treatment is usually to use a drug to prevent a symptom and the choices for treatment diminish as attention is focused on the potential complications of that drug. Direct to consumer ads are, perhaps, the worst example of how attention is focused on the benefits rather than the possible side effects, even when they are very dangerous. Read more: Are Drug Warning Labels Preventing Side Effects? - Video … Continue reading →

10-07-2012 23:59 NOTE - this video is not intended to dismiss the seriousness of ADD or ADHD - it is only a comedy. In the video poor Eddy is the unlucky 1 millionth customer that has all the side effects of his medication including permanent mental damage, tics, nausea, cardiovascular reaction, vomiting, nervousness and sudden death. Like many comedies there is a serious side to the video. Matt the writer / producer was the unfortunate 1 in 1000 once and suffered severe stomatitss in which the whole inside of the mouth becomes a canker sore as a reaction to a drug for pink eye. With GlaxoSmithKline / GSK recently pleading guilty to medical fraud and paying the largest ever such settlement of 3 billion dollars one can question the safety of new drugs. Psychiatric drugs in particular seem to troubled past with some drugs more reliably causing the side effects than curing the symptoms intended by usage. The idea was inspired when a video came on for a drug and there were so many side effects that I literally thought I switched the channel to a Saturday Night Live commercial. Special thanks to Halkidiki the Macho Doll for letting me … Continue reading →

The biological role of a gene variant implicated in multiple sclerosis (MS) has been determined by researchers at Oxford University. The finding explains why MS patients do badly on a set of drugs used successfully in other autoimmune diseases, such as rheumatoid arthritis and inflammatory bowel disease - something that has been a puzzle for over 10 years. The study illustrates that understanding the details of how some changes in the DNA code are linked to common diseases can inform clinical practice and guide the treatments that people receive so as to prevent adverse side effects. The Oxford University team, along with German, Danish and US colleagues, has published the findings in the journal Nature. They were funded through the MRC Human Immunology Unit, part of the MRC Weatherall Institute of Molecular Medicine, and the Wellcome Trust. "The hope has been that analyses of the whole human genome would lead to findings that are clinically relevant," stated Professor Lars Fugger of the Nuffield Department of Clinical Neurosciences at Oxford University, who led the work. "We show that this is possible. It's one of the first such examples, certainly in autoimmune disease." Like us on Facebook Gene scientists in recent years … Continue reading →

The new drug will be tested on patients with lymphoma and leukaemia. Photo: Phil Carrick MELBOURNE scientists believe they have found a new treatment for blood cancers that will spare patients the unpleasant side effects of chemotherapy. The new drug, which has shown promising results in mice, will be tested on patients with lymphoma and leukaemia at Peter MacCallum Cancer Centre later this year. In a career-defining breakthrough, Associate Professor Ross Hannan from the hospital found a weakness in cancer cells that could be targeted to kill them while sparing healthy cells. The weakness is a process called ribosome biogenesis, which produces proteins essential for the growth and survival of all cells. Advertisement ''We've demonstrated that cancer cells are far more dependent on their ability to make ribosomes than normal cells, and therefore, much more vulnerable if these ''protein factories" come under attack,'' he said of the research published yesterday in the journal Cancer Cell. After working with an American pharmaceutical company, Professor Hannam and his colleagues found a drug that could target this process, killing the cancer cells in mice with little impact on healthy cells. Professor Grant McArthur, co-head of the Cancer Therapeutics Program at Peter MacCallum Cancer … Continue reading →

AUSTRALIAN scientists believe they have found a treatment for blood cancers that will spare patients the unpleasant side-effects of chemotherapy. The new drug, which has shown promising results in mice, will be tested on patients with lymphoma and leukaemia at Peter MacCallum Cancer Centre in Melbourne this year. An Associate Professor, Ross Hannan, from the hospital, found a weakness in cancer cells that could be targeted to kill them while sparing healthy cells. The weakness is a process called ribosome biogenesis, which produces proteins essential for the growth and survival of all cells. ''We've demonstrated that cancer cells are far more dependent on their ability to make ribosomes than normal cells, and therefore, much more vulnerable if these 'protein factories' come under attack,'' he said of the research, published today in the journal Cancer Cell. Advertisement After working with an American pharmaceutical company, Associate Professor Hannan and his colleagues found a drug that could target this process, killing the cancer cells in mice with little effect on healthy cells. A professor and co-head of the cancer therapeutics program at Peter MacCallum Cancer Centre, Grant McArthur, said: ''This will hopefully lead to the eradication of lymphoma and leukaemia cells in patients.'' … Continue reading →

By Jo Macfarlane PUBLISHED: 16:48 EST, 7 July 2012 | UPDATED: 16:48 EST, 7 July 2012 One of the worlds biggest drug companies is at the centre of an urgent investigation after failing to disclose reports that 15,000 people died while taking its medicines. Swiss pharmaceutical giant Roche failed to pass on a further 65,000 reports of suspected side effects that were recorded by patients. All of the reactions took place in the United States over the past 15 years with medicines used to treat breast cancer, bowel cancer, hepatitis B, and skin and eye conditions. Roche, one of the world's biggest drug companies, is at the centre of an urgent investigation after failing to report that people died while taking their medication There is no evidence so far of any direct link between the problems and the drugs but medicines watchdogs say they are taking Roches failure to disclose possible concerns extremely seriously. The drugs involved include Herceptin, given to about 10,000 breast cancer patients in Britain, and Lucentis, which is used to treat about 20,000 UK patients a year with age-related vision loss. The NHS pays Roche millions of pounds for these treatments every year. The extent of … Continue reading →

Posted by Shezad Malik MD JDJuly 06, 2012 11:34 PM As an Actos Bladder Cancer attorney I have written extensively of the alleged injuries of bladder cancer with the use of the newer diabetic drug, Actos. A recent Canadian mega study has linked the dangerous life threatening side effects of Actos to an increased risk of bladder cancer. According to medical researchers there is an association between the Actos and bladder cancer. This research was published in this month issue of the Canadian Medical Journal. Thiazolidinediones, especially Actos (pioglitazone), may increase the risk of bladder cancer. The researchers conducted a systematic review and meta-analysis to evaluate the risk of bladder cancer among adults with type 2 diabetes taking thiazolidinediones.The study found that there is a 22% increased risk of bladder cancer among patients with type 2 diabetes using Actos or another drug belonging to the same class of medications, known as thiazolidinediones. Other Studies Confirming Link between Actos and Bladder Cancer In April, Health Canada modified the warning label on Actos to include the possible increased risk of bladder cancer with continual exposure. Late last month, a Canadian study published in the British Medical Journal found a two-fold increased risk … Continue reading →